BILL HOLDINGS INC (BILL)

US0900431000 - Common Stock

62.42  -0.08 (-0.13%)

After market: 62.42 0 (0%)

Fundamental Rating

4

Taking everything into account, BILL scores 4 out of 10 in our fundamental rating. BILL was compared to 275 industry peers in the Software industry. Both the profitability and financial health of BILL have multiple concerns. BILL is not overvalued while it is showing excellent growth. This is an interesting combination.



3

1. Profitability

1.1 Basic Checks

In the past year BILL was profitable.
In the past year BILL had a positive cash flow from operations.
BILL had negative earnings in each of the past 5 years.
In multiple years BILL reported negative operating cash flow during the last 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -1.17%, BILL is in the better half of the industry, outperforming 65.45% of the companies in the same industry.
With a decent Return On Equity value of -2.92%, BILL is doing good in the industry, outperforming 66.91% of the companies in the same industry.
Industry RankSector Rank
ROA -1.17%
ROE -2.92%
ROIC N/A
ROA(3y)-2.5%
ROA(5y)-1.85%
ROE(3y)-5.82%
ROE(5y)-5.21%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BILL has a Gross Margin of 81.90%. This is amongst the best in the industry. BILL outperforms 88.36% of its industry peers.
In the last couple of years the Gross Margin of BILL has grown nicely.
BILL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 81.9%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.81%
GM growth 5Y3.09%

3

2. Health

2.1 Basic Checks

BILL does not have a ROIC to compare to the WACC, probably because it is not profitable.
BILL has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BILL has more shares outstanding
The debt/assets ratio for BILL has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 0.91, we must say that BILL is in the distress zone and has some risk of bankruptcy.
BILL has a Altman-Z score of 0.91. This is in the lower half of the industry: BILL underperforms 64.36% of its industry peers.
BILL has a debt to FCF ratio of 8.43. This is a slightly negative value and a sign of low solvency as BILL would need 8.43 years to pay back of all of its debts.
BILL's Debt to FCF ratio of 8.43 is in line compared to the rest of the industry. BILL outperforms 53.45% of its industry peers.
A Debt/Equity ratio of 0.47 indicates that BILL is not too dependend on debt financing.
BILL's Debt to Equity ratio of 0.47 is on the low side compared to the rest of the industry. BILL is outperformed by 63.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 8.43
Altman-Z 0.91
ROIC/WACCN/A
WACC8.74%

2.3 Liquidity

BILL has a Current Ratio of 1.69. This is a normal value and indicates that BILL is financially healthy and should not expect problems in meeting its short term obligations.
BILL has a Current ratio (1.69) which is comparable to the rest of the industry.
BILL has a Quick Ratio of 1.69. This is a normal value and indicates that BILL is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of BILL (1.69) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.69
Quick Ratio 1.69

7

3. Growth

3.1 Past

BILL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 402.22%, which is quite impressive.
BILL shows a strong growth in Revenue. In the last year, the Revenue has grown by 39.08%.
The Revenue has been growing by 74.80% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)402.22%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q50%
Revenue 1Y (TTM)39.08%
Revenue growth 3Y88.67%
Revenue growth 5Y74.8%
Revenue growth Q2Q22.5%

3.2 Future

BILL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.61% yearly.
The Revenue is expected to grow by 17.95% on average over the next years. This is quite good.
EPS Next Y37.93%
EPS Next 2Y23.66%
EPS Next 3Y22.36%
EPS Next 5Y17.61%
Revenue Next Year19.15%
Revenue Next 2Y16.56%
Revenue Next 3Y18.3%
Revenue Next 5Y17.95%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 27.62, BILL can be considered very expensive at the moment.
Based on the Price/Earnings ratio, BILL is valued a bit cheaper than 78.18% of the companies in the same industry.
BILL is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 24.83, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 24.74, the valuation of BILL can be described as rather expensive.
Based on the Price/Forward Earnings ratio, BILL is valued a bit cheaper than 77.45% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.32, BILL is valued at the same level.
Industry RankSector Rank
PE 27.62
Fwd PE 24.74

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, BILL is valued a bit cheaper than 76.36% of the companies in the same industry.
Industry RankSector Rank
P/FCF 30.01
EV/EBITDA N/A

4.3 Compensation for Growth

BILL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BILL's earnings are expected to grow with 22.36% in the coming years.
PEG (NY)0.73
PEG (5Y)N/A
EPS Next 2Y23.66%
EPS Next 3Y22.36%

0

5. Dividend

5.1 Amount

No dividends for BILL!.
Industry RankSector Rank
Dividend Yield N/A

BILL HOLDINGS INC

NYSE:BILL (4/17/2024, 7:04:00 PM)

After market: 62.42 0 (0%)

62.42

-0.08 (-0.13%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap6.56B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 27.62
Fwd PE 24.74
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.73
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.17%
ROE -2.92%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 81.9%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.69
Quick Ratio 1.69
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)402.22%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y37.93%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)39.08%
Revenue growth 3Y88.67%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y